Psilocybin and other psychedelics have shown efficacy in treating several mental illnesses, including treatment-resistant cases, through clinical trials. In psychedelic assisted psychotherapy, these substances enhance psychotherapeutic processes. Psychohistoriographic Brief Therapy, developed in Jamaica, has successfully treated personality disorders by documenting life experiences in a psychohistoriogram. The De La Haye psilocybin Treatment Protocol combines micro-doses of psilocybin mushrooms over eight weeks with this documentation, followed by a supervised larger dose in the ninth week. Given Jamaica's legal status for psilocybin, a regulated industry could support rigorous clinical research and benefit clients in this new psychiatric frontier.
Medical training often overlooks culturally adapted tools that respect patients' beliefs and realities. In Ethiopia, transformative learning theory helped bridge biomedical and traditional healing for psychosis; only 58% of rural patients access biomedical care, with most relying on Orthodox Christian traditional healers who are less stigmatized. Collaborative partnerships between spiritual healers and researchers reduced stigma and increased referrals to psychiatric clinics. Low parental mental health literacy and stigma are fundamental treatment barriers across Ethiopia, Kenya, and Democratic Republic of Congo. One paper from an LMIC cohort uses psilocybin in psychotherapy. Creative arts modalities, including Zentangle, offer accessible, transportable treatment for serious mental illness. In Qatar, 75% of the population are migrant workers, yet community mental health services remain underdeveloped, especially for children, women, and migrants.